A possible role for toll-like receptor (TLR) 5 in fibrotic pulmonary sarcoidosis Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008
LSC 2010 Abstract: Defective toll-like receptor-3 (TLR3) function promotes persistent interstitial lung disease and fibrosis in sarcoidosis Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms Year: 2010
Toll-like receptor (TLR) 9 genetics in sarcoidosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 520s Year: 2006
Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21 Source: Eur Respir J 2007; 29: 1082-1093 Year: 2007
Increased expression of toll-like receptor 2 (TLR2) in the small airways of fatal asthma Source: Eur Respir J 2007; 30: Suppl. 51, 285s Year: 2007
CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 25: 701-707 Year: 2005
Altered expression of toll-like receptor (TLR)-2 and TLR-4 on alveolar macrophages (AM) in inflammatory lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 588s Year: 2003
Cykine/receptor inflammatory profile in different types of idiopathic intestitial pneumonias (IIPs). Key role of Fas Ligand recruvation in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Upregulation of interleukin 13 receptor alpha 2 (IL-13RA2) expression in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005
Expression of toll-like receptor 3 in alveolar macrophages from patients with COPD Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010
Longterm treatment effects of pulmonary hypertantion (PH) in idiopathic pulmonary fibrosis (IPF) patients by endothelin receptor blockade (Bosentan) Source: Eur Respir J 2007; 30: Suppl. 51, 120s Year: 2007
Fractalkine and its receptor (CX3CR1) in primary pulmonary hypertension (PPH) Source: Eur Respir J 2001; 18: Suppl. 33, 2s Year: 2001
Aerosolized interferon-gamma (IFN-γ) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation Year: 2007
Enhanced apoptosis of alveolar lymphocytes (AL), but not macrophages (AM) in interstitial idiopathic pneumonias (IIPs). Special attention to idiopathic pulmonary fibrosis (IPF) results Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010
Association between AGTTGFB1ESR1, and VDR gene variants with idiopathic pulmonary fibrosis (IPF) and pulmonary sarcoidosis (PS) clinical features Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases Year: 2017
Neutrophil chemokine receptor (CXCR1 and 2) gene expression and biopsy neutrophilia in severe exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001
Toll-like receptor (TLR) 2 promotor polymorphism is associated with the disease course in sarcoidosis patients Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006
Differential expression of stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular disease: a bronchoalveolar la Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008
Influence of Toll-like receptor 4 (TLR4) on cellular signaling of acute lung injury Source: Eur Respir J 2003; 22: Suppl. 45, 268s Year: 2003
The role of IL-10 receptors in aberrant homeostatic control of TNF-α in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2002; 20: Suppl. 38, 599s Year: 2002